Close
4

Athena Athena

X

Find Ulotaront manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Looking for 1310426-33-5 / Ulotaront API manufacturers, exporters & distributors?

Ulotaront manufacturers, exporters & distributors 1

31

PharmaCompass offers a list of Ulotaront API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ulotaront manufacturer or Ulotaront supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ulotaront manufacturer or Ulotaront supplier.

PharmaCompass also assists you with knowing the Ulotaront API Price utilized in the formulation of products. Ulotaront API Price is not always fixed or binding as the Ulotaront Price is obtained through a variety of data sources. The Ulotaront Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ulotaront

Synonyms

Sep-363856, Unii-3k6270mg59, Sep-856, 1310426-33-5, 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine, 3k6270mg59

Cas Number

1310426-33-5

Unique Ingredient Identifier (UNII)

3K6270MG59

About Ulotaront

SEP-363856 is a novel psychotropic drug being investigated for the treatment of schizophrenia. Unlike other drugs used for this condition, SEP-363856 does not bind to the dopamine D2 receptors, but exerts actions on the trace amineassociated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT1A). SEP-363856 was developed by Sunovion pharmaceuticals. An initial clinical study has shown this drug may be effective against both positive and negative symptoms of schizophrenia. Negative symptoms of schizophrenia are more difficult to treat and may include flattened affect, anhedonia, and social withdrawal. Additional clinical trials of SEP-363856 are required to confirm the safety and efficacy of this drug.

SEP-363856 Manufacturers

A SEP-363856 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SEP-363856, including repackagers and relabelers. The FDA regulates SEP-363856 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SEP-363856 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

SEP-363856 Suppliers

A SEP-363856 supplier is an individual or a company that provides SEP-363856 active pharmaceutical ingredient (API) or SEP-363856 finished formulations upon request. The SEP-363856 suppliers may include SEP-363856 API manufacturers, exporters, distributors and traders.

SEP-363856 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing SEP-363856 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for SEP-363856 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture SEP-363856 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain SEP-363856 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a SEP-363856 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of SEP-363856 suppliers with NDC on PharmaCompass.

SEP-363856 GMP

SEP-363856 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of SEP-363856 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SEP-363856 GMP manufacturer or SEP-363856 GMP API supplier for your needs.

SEP-363856 CoA

A SEP-363856 CoA (Certificate of Analysis) is a formal document that attests to SEP-363856's compliance with SEP-363856 specifications and serves as a tool for batch-level quality control.

SEP-363856 CoA mostly includes findings from lab analyses of a specific batch. For each SEP-363856 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

SEP-363856 may be tested according to a variety of international standards, such as European Pharmacopoeia (SEP-363856 EP), SEP-363856 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SEP-363856 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY